IBDEI378 ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,53740,1,4,0)
 ;;=4^35216
 ;;^UTILITY(U,$J,358.3,53741,0)
 ;;=35276^^252^2717^5^^^^1
 ;;^UTILITY(U,$J,358.3,53741,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53741,1,2,0)
 ;;=2^RPR BLD VESSEL,W/ GRAFT OTH THAN VEIN
 ;;^UTILITY(U,$J,358.3,53741,1,4,0)
 ;;=4^35276
 ;;^UTILITY(U,$J,358.3,53742,0)
 ;;=35685^^252^2717^1^^^^1
 ;;^UTILITY(U,$J,358.3,53742,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53742,1,2,0)
 ;;=2^BYPASS GRAFT PATENCY/PATCH
 ;;^UTILITY(U,$J,358.3,53742,1,4,0)
 ;;=4^35685
 ;;^UTILITY(U,$J,358.3,53743,0)
 ;;=I27.9^^253^2718^1
 ;;^UTILITY(U,$J,358.3,53743,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53743,1,3,0)
 ;;=3^Pulmonary heart disease, unspecified
 ;;^UTILITY(U,$J,358.3,53743,1,4,0)
 ;;=4^I27.9
 ;;^UTILITY(U,$J,358.3,53743,2)
 ;;=^5007154
 ;;^UTILITY(U,$J,358.3,53744,0)
 ;;=D61.09^^253^2719^4
 ;;^UTILITY(U,$J,358.3,53744,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53744,1,3,0)
 ;;=3^Constitutional aplastic anemia NEC
 ;;^UTILITY(U,$J,358.3,53744,1,4,0)
 ;;=4^D61.09
 ;;^UTILITY(U,$J,358.3,53744,2)
 ;;=^334036
 ;;^UTILITY(U,$J,358.3,53745,0)
 ;;=D61.810^^253^2719^1
 ;;^UTILITY(U,$J,358.3,53745,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53745,1,3,0)
 ;;=3^Antineoplastic chemotherapy induced pancytopenia
 ;;^UTILITY(U,$J,358.3,53745,1,4,0)
 ;;=4^D61.810
 ;;^UTILITY(U,$J,358.3,53745,2)
 ;;=^5002339
 ;;^UTILITY(U,$J,358.3,53746,0)
 ;;=D61.2^^253^2719^2
 ;;^UTILITY(U,$J,358.3,53746,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53746,1,3,0)
 ;;=3^Aplastic anemia due to other external agents
 ;;^UTILITY(U,$J,358.3,53746,1,4,0)
 ;;=4^D61.2
 ;;^UTILITY(U,$J,358.3,53746,2)
 ;;=^5002337
 ;;^UTILITY(U,$J,358.3,53747,0)
 ;;=D61.1^^253^2719^5
 ;;^UTILITY(U,$J,358.3,53747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53747,1,3,0)
 ;;=3^Drug-induced aplastic anemia
 ;;^UTILITY(U,$J,358.3,53747,1,4,0)
 ;;=4^D61.1
 ;;^UTILITY(U,$J,358.3,53747,2)
 ;;=^5002336
 ;;^UTILITY(U,$J,358.3,53748,0)
 ;;=D61.89^^253^2719^3
 ;;^UTILITY(U,$J,358.3,53748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53748,1,3,0)
 ;;=3^Aplastic anemias and other bone marrow failure syndromes NEC
 ;;^UTILITY(U,$J,358.3,53748,1,4,0)
 ;;=4^D61.89
 ;;^UTILITY(U,$J,358.3,53748,2)
 ;;=^5002341
 ;;^UTILITY(U,$J,358.3,53749,0)
 ;;=K40.90^^253^2720^3
 ;;^UTILITY(U,$J,358.3,53749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53749,1,3,0)
 ;;=3^Unil inguinal hernia w/o obstruction or gangrene
 ;;^UTILITY(U,$J,358.3,53749,1,4,0)
 ;;=4^K40.90
 ;;^UTILITY(U,$J,358.3,53749,2)
 ;;=^5008591
 ;;^UTILITY(U,$J,358.3,53750,0)
 ;;=K42.9^^253^2720^2
 ;;^UTILITY(U,$J,358.3,53750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53750,1,3,0)
 ;;=3^Umbilical hernia w/o obstruction or gangrene
 ;;^UTILITY(U,$J,358.3,53750,1,4,0)
 ;;=4^K42.9
 ;;^UTILITY(U,$J,358.3,53750,2)
 ;;=^5008606
 ;;^UTILITY(U,$J,358.3,53751,0)
 ;;=K43.9^^253^2720^4
 ;;^UTILITY(U,$J,358.3,53751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53751,1,3,0)
 ;;=3^Ventral hernia w/o obstruction or gangrene
 ;;^UTILITY(U,$J,358.3,53751,1,4,0)
 ;;=4^K43.9
 ;;^UTILITY(U,$J,358.3,53751,2)
 ;;=^5008615
 ;;^UTILITY(U,$J,358.3,53752,0)
 ;;=K43.2^^253^2720^1
 ;;^UTILITY(U,$J,358.3,53752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53752,1,3,0)
 ;;=3^Incisional hernia w/o obstruction or gangrene
 ;;^UTILITY(U,$J,358.3,53752,1,4,0)
 ;;=4^K43.2
 ;;^UTILITY(U,$J,358.3,53752,2)
 ;;=^5008609
 ;;^UTILITY(U,$J,358.3,53753,0)
 ;;=N17.0^^253^2721^1
 ;;^UTILITY(U,$J,358.3,53753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,53753,1,3,0)
 ;;=3^Acute kidney failure with tubular necrosis
